Wellington Management announced it will acquire Hartford Funds, expected to close in 2027’s first quarter, internalizing roughly USD 130 billion of the USD 1.35 trillion manager’s assets that it has long subadvised for the fund family (which holds USD 160 billion total). Hartford Funds will be rebranded as Wellington.
The Hartford Healthcare Fund Class I HGHIX
- NAV / 1-Day Return 45.12 / −0.24 %
- Total Assets 776.3M
-
Adj. Expense Ratio
1.050%
- Expense Ratio 1.050%
- Distribution Fee Level Above Average
- Share Class Type Institutional
- Category Health
- Investment Style Large Value
- Min. Initial Investment 2,000
- Status Open
- TTM Yield 0.00
- Turnover 49%
USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 12:11 AM GMT+0
Morningstar’s Analysis HGHIX
Will HGHIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 48.0
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 12.72 | 93M | Healthcare |
Merck & Co Inc | 6.81 | 50M | Healthcare |
Johnson & Johnson | 5.66 | 41M | Healthcare |
UnitedHealth Group Inc | 4.91 | 36M | Healthcare |
Intuitive Surgical Inc | 3.39 | 25M | Healthcare |
Elevance Health Inc | 3.19 | 23M | Healthcare |
AbbVie Inc | 3.16 | 23M | Healthcare |
Abbott Laboratories | 2.81 | 21M | Healthcare |
Danaher Corp | 2.72 | 20M | Healthcare |
CVS Health Corp | 2.65 | 19M | Healthcare |
United States